---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-22-000764"
form_type: "8-K"
ticker: "PMDI"
cik: "0000806517"
company_name: "PSYCHEMEDICS CORP"
filed_at: "2022-02-03T23:59:59+00:00"
generated_at: "2026-06-27T12:02:38.982500+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Psychemedics approves 2022 cash bonus plan for execs; up to 25% of base salary

## Summary
- Bonus up to 25% of base salary based on domestic sales plan (7.5%), EPS target (7.5%), and individual goals (10%).
- Participants include CEO, Executive VP, VP Lab Ops, and VP Controller.
- CEO will assess other execs' individual goals; Compensation Committee determines final payouts.
- Committee reserves right to amend or terminate bonus arrangements at any time.

## SEC filing metadata
- accession: 0001171843-22-000764
- form_type: 8-K
- ticker: PMDI
- cik: 0000806517
- company_name: PSYCHEMEDICS CORP
- filed_at: 2022-02-03T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/806517/000117184322000764/0001171843-22-000764-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/806517/000117184322000764/f8k_020322.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-22-000764
- JSON: https://secwatch.observer/filing/0001171843-22-000764.json
- Plain text: https://secwatch.observer/filing/0001171843-22-000764.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.